Thalidomide and its derivates induce degradation of many C₂H₂ zinc-finger transcription factors, including SALL4, providing insight into a long-standing mystery in modern pharmacology, and starting points for future drug development.

A transcription factor called SALL4 could be the missing link between thalidomide and the limb defects caused by the drug.